![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | increases expression | EXP | | 6480464 | ethylene dichloride results in increased expression of MRPL19 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of MRPL19 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL19 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of MRPL19 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1349255 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MRPL19 mRNA | CTD | PMID:20106945 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MRPL19 mRNA | CTD | PMID:21354282 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL19 mRNA | CTD | PMID:17942748 | 2,6-dinitrotoluene | affects expression | ISO | RGD:1587381 | 6480464 | 2, 6-dinitrotoluene affects the expression of MRPL19 mRNA | CTD | PMID:21346803 | 2-hydroxyethyl methacrylate | increases expression | ISO | RGD:1349255 | 6480464 | hydroxyethyl methacrylate results in increased expression of MRPL19 mRNA | CTD | PMID:30497689 | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | 3 more ... | CTD | PMID:19467301 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1349255 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPL19 mRNA | CTD | PMID:28628672 | acrylamide | decreases expression | ISO | RGD:1587381 | 6480464 | Acrylamide results in decreased expression of MRPL19 mRNA | CTD | PMID:28959563 | atrazine | increases expression | ISO | RGD:1349255 | 6480464 | Atrazine results in increased expression of MRPL19 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | affects methylation | ISO | RGD:1349255 | 6480464 | Benzoapyrene affects the methylation of MRPL19 promoter | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | RGD:1587381 | 6480464 | bisphenol A results in increased expression of MRPL19 mRNA | CTD | PMID:25181051 | bisphenol F | multiple interactions | ISO | RGD:1349255 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPL19 mRNA | CTD | PMID:28628672 | bortezomib | increases expression | ISO | RGD:1349255 | 6480464 | Bortezomib results in increased expression of MRPL19 mRNA | CTD | PMID:20977926 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of MRPL19 mRNA | CTD | PMID:20883709 | caffeine | decreases expression | ISO | RGD:1587381 | 6480464 | Caffeine results in decreased expression of MRPL19 mRNA | CTD | PMID:20864626 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes, Carbon results in increased expression of MRPL19 mRNA | CTD | PMID:25554681 | chromium(6+) | affects expression | EXP | | 6480464 | chromium hexavalent ion affects the expression of MRPL19 mRNA | CTD | PMID:28472532 | copper(II) sulfate | decreases expression | ISO | RGD:1349255 | 6480464 | Copper Sulfate results in decreased expression of MRPL19 mRNA | CTD | PMID:19549813 | dexamethasone | multiple interactions | ISO | RGD:1349255 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPL19 mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of MRPL19 mRNA | CTD | PMID:21266533 | ethyl methanesulfonate | decreases expression | ISO | RGD:1349255 | 6480464 | Ethyl Methanesulfonate results in decreased expression of MRPL19 mRNA | CTD | PMID:23649840 | finasteride | increases expression | ISO | RGD:1587381 | 6480464 | Finasteride results in increased expression of MRPL19 mRNA | CTD | PMID:24136188 | flutamide | increases expression | ISO | RGD:1587381 | 6480464 | Flutamide results in increased expression of MRPL19 mRNA | CTD | PMID:24136188 | formaldehyde | decreases expression | ISO | RGD:1349255 | 6480464 | Formaldehyde results in decreased expression of MRPL19 mRNA | CTD | PMID:23649840 | hydrogen peroxide | increases expression | ISO | RGD:1349255 | 6480464 | Hydrogen Peroxide results in increased expression of MRPL19 mRNA | CTD | PMID:18951874 | indometacin | multiple interactions | ISO | RGD:1349255 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPL19 mRNA | CTD | PMID:28628672 | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of MRPL19 mRNA | CTD | PMID:21829687 | leflunomide | increases expression | ISO | RGD:1587381 | 6480464 | leflunomide results in increased expression of MRPL19 mRNA | CTD | PMID:24136188 | lipopolysaccharide | decreases expression | ISO | RGD:1349255 | 6480464 | Lipopolysaccharides results in decreased expression of MRPL19 mRNA | CTD | PMID:31059760 | methoxyacetic acid | decreases expression | ISO | RGD:1587381 | 6480464 | methoxyacetic acid results in decreased expression of MRPL19 mRNA | CTD | PMID:20864626 | methyl methanesulfonate | decreases expression | ISO | RGD:1349255 | 6480464 | Methyl Methanesulfonate results in decreased expression of MRPL19 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | RGD:1587381 | 6480464 | methylmercuric chloride results in decreased expression of MRPL19 mRNA | CTD | PMID:20864626 | methylmercury chloride | decreases expression | ISO | RGD:1349255 | 6480464 | methylmercuric chloride results in decreased expression of MRPL19 mRNA | CTD | PMID:28001369 | methylseleninic acid | decreases expression | ISO | RGD:1349255 | 6480464 | methylselenic acid results in decreased expression of MRPL19 mRNA | CTD | PMID:18548127 | Monobutylphthalate | decreases expression | ISO | RGD:1587381 | 6480464 | monobutyl phthalate results in decreased expression of MRPL19 mRNA | CTD | PMID:20864626 | nefazodone | increases expression | ISO | RGD:1587381 | 6480464 | nefazodone results in increased expression of MRPL19 mRNA | CTD | PMID:24136188 | nimesulide | increases expression | ISO | RGD:1587381 | 6480464 | nimesulide results in increased expression of MRPL19 mRNA | CTD | PMID:24136188 | paracetamol | decreases expression | ISO | RGD:1349255 | 6480464 | Acetaminophen results in decreased expression of MRPL19 mRNA | CTD | PMID:25704631 more ... | propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of MRPL19 mRNA | CTD | PMID:19363144 | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of MRPL19 mRNA | CTD | PMID:22610192 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MRPL19 mRNA | CTD | PMID:20883709 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MRPL19 mRNA | CTD | PMID:31919559 | urethane | decreases expression | ISO | RGD:1349255 | 6480464 | Urethane results in decreased expression of MRPL19 mRNA | CTD | PMID:28818685 | |